Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 40  Show
  1. 1
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  2. 2
    "The DNA sequence and comparative analysis of human chromosome 20."
    Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P., Bird C.P., Blakey S.E.
    Rogers J.
    Nature 414:865-871(2001) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1563 other entries.

  3. 3
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  4. 4
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Category: Sequences.
    Tissue: Uterus.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50477 other entries.

  5. 5
    "Novel GATA5 loss-of-function mutations underlie familial atrial fibrillation."
    Gu J.Y., Xu J.H., Yu H., Yang Y.Q.
    Clinics (Sao Paulo) 67:1393-1399(2012) [PubMed] [Europe PMC] [Abstract]
    Cited for: INVOLVEMENT IN CHTD5, VARIANTS CHTD5 PHE-138 AND GLY-210, CHARACTERIZATION OF VARIANTS CHTD5 PHE-138 AND GLY-210.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  6. 6
    "Mutational spectrum of the GATA5 gene associated with familial atrial fibrillation."
    Yang Y.Q., Wang J., Wang X.H., Wang Q., Tan H.W., Zhang M., Shen F.F., Jiang J.Q., Fang W.Y., Liu X.
    Int. J. Cardiol. 157:305-307(2012) [PubMed] [Europe PMC] [Abstract]
    Cited for: INVOLVEMENT IN CHTD5, VARIANTS CHTD5 VAL-184; THR-218 AND PRO-266.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  7. 7
    "Rare non-synonymous variations in the transcriptional activation domains of GATA5 in bicuspid aortic valve disease."
    Padang R., Bagnall R.D., Richmond D.R., Bannon P.G., Semsarian C.
    J. Mol. Cell. Cardiol. 53:277-281(2012) [PubMed] [Europe PMC] [Abstract]
    Cited for: INVOLVEMENT IN CHTD5, VARIANT CHTD5 HIS-142, VARIANTS ARG-3; TRP-19; PRO-67 AND SER-166.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  8. 8
    "Prevalence and spectrum of GATA5 mutations associated with congenital heart disease."
    Jiang J.Q., Li R.G., Wang J., Liu X.Y., Xu Y.J., Fang W.Y., Chen X.Z., Zhang W., Wang X.Z., Yang Y.Q.
    Int. J. Cardiol. 165:570-573(2013) [PubMed] [Europe PMC] [Abstract]
    Cited for: INVOLVEMENT IN CHTD5, VARIANTS CHTD5 GLY-132; ALA-190; HIS-223 AND ARG-274.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  9. 9
    "GATA5 loss-of-function mutations underlie tetralogy of fallot."
    Wei D., Bao H., Liu X.Y., Zhou N., Wang Q., Li R.G., Xu Y.J., Yang Y.Q.
    Int. J. Med. Sci. 10:34-42(2013) [PubMed] [Europe PMC] [Abstract]
    Cited for: INVOLVEMENT IN CHTD5, VARIANTS CHTD5 GLY-187 AND ARG-207, CHARACTERIZATION OF CHTD5 VARIANTS GLY-187 AND ARG-207, FUNCTION.
    Category: Function, Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  10. 10
    "A novel GATA5 loss-of-function mutation underlies lone atrial fibrillation."
    Wang X.H., Huang C.X., Wang Q., Li R.G., Xu Y.J., Liu X., Fang W.Y., Yang Y.Q.
    Int. J. Mol. Med. 31:43-50(2013) [PubMed] [Europe PMC] [Abstract]
    Cited for: INVOLVEMENT IN CHTD5, VARIANT CHTD5 GLY-200, CHARACTERIZATION OF VARIANT CHTD5 GLY-200.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  11. 11
    "GATA5 loss-of-function mutation responsible for the congenital ventriculoseptal defect."
    Wei D., Bao H., Zhou N., Zheng G.F., Liu X.Y., Yang Y.Q.
    Pediatr. Cardiol. 34:504-511(2013) [PubMed] [Europe PMC] [Abstract]
    Cited for: INVOLVEMENT IN CHTD5, VARIANT CHTD5 VAL-199, CHARACTERIZATION OF VARIANT CHTD5 VAL-199.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  12. 12
    "GATA5 loss-of-function mutations associated with congenital bicuspid aortic valve."
    Shi L.M., Tao J.W., Qiu X.B., Wang J., Yuan F., Xu L., Liu H., Li R.G., Xu Y.J., Wang Q., Zheng H.Z., Li X., Wang X.Z., Zhang M., Qu X.K., Yang Y.Q.
    Int. J. Mol. Med. 33:1219-1226(2014) [PubMed] [Europe PMC] [Abstract]
    Cited for: INVOLVEMENT IN CHTD5, VARIANTS CHTD5 ASP-16 AND PRO-252, CHARACTERIZATION OF VARIANTS CHTD5 ASP-16 AND PRO-252.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  13. 13
    "Somatic GATA5 mutations in sporadic tetralogy of Fallot."
    Huang R.T., Xue S., Xu Y.J., Zhou M., Yang Y.Q.
    Int. J. Mol. Med. 33:1227-1235(2014) [PubMed] [Europe PMC] [Abstract]
    Cited for: INVOLVEMENT IN CHTD5, VARIANTS CHTD5 GLU-203 AND 208-TYR--ALA-397 DEL, CHARACTERIZATION OF VARIANTS CHTD5 GLU-203 AND 208-TYR--ALA-397 DEL.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  14. 14
    Cited for: INVOLVEMENT IN CHTD5, VARIANT CHTD5 ASP-240, CHARACTERIZATION OF VARIANT CHTD5 ASP-240, FUNCTION.
    Category: Function, Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  15. 15
    "Physical interaction between GATA-5 and hepatocyte nuclear factor-1alpha results in synergistic activation of the human lactase-phlorizin hydrolase promoter."
    van Wering H.M., Huibregtse I.L., van der Zwan S.M., de Bie M.S., Dowling L.N., Boudreau F., Rings E.H., Grand R.J., Krasinski S.D.
    J. Biol. Chem. 277:27659-27667(2002) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Annotation: demonstrate that GATA-5 and HNF-1alpha physically associate both in vivo and in vitro and that this interaction is necessary for cooperative activation of the lactase-phlorizin hydrolase promoterImported.
    Source: GeneRIF:140628.

    This publication is mapped to 22 other entries.

  16. 16
    "GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer."
    Akiyama Y., Watkins N., Suzuki H., Jair K.W., van Engeland M., Esteller M., Sakai H., Ren C.Y., Yuasa Y., Herman J.G., Baylin S.B.
    Mol. Cell. Biol. 23:8429-8439(2003) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: in colorectal cancer and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5Imported.
    Source: GeneRIF:140628.

    This publication is mapped to 16 other entries.

  17. 17
    "Hypermethylation of the GATA genes in lung cancer."
    Guo M., Akiyama Y., House M.G., Hooker C.M., Heath E., Gabrielson E., Yang S.C., Han Y., Baylin S.B., Herman J.G., Brock M.V.
    Clin. Cancer Res. 10:7917-7924(2004) [PubMed] [Europe PMC] [Abstract]
    Category: Expression, Sequences.
    Annotation: Hypermethylation of the GATA5 is associated with lung cancerImported.
    Source: GeneRIF:140628.

    This publication is mapped to 16 other entries.

  18. 18
    "Involvement of GATA-4/-5 transcription factors in ovarian carcinogenesis."
    Wakana K., Akiyama Y., Aso T., Yuasa Y.
    Cancer Lett. 241:281-288(2006) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: Methylation of GATA-5 was associated with ovarian carcinogenesisImported.
    Source: GeneRIF:140628.

    This publication is mapped to 16 other entries.

  19. 19
    "Hypermethylation of the GATA gene family in esophageal cancer."
    Guo M., House M.G., Akiyama Y., Qi Y., Capagna D., Harmon J., Baylin S.B., Brock M.V., Herman J.G.
    Int. J. Cancer 119:2078-2083(2006) [PubMed] [Europe PMC] [Abstract]
    Category: Expression, Sequences.
    Annotation: Frequent silencing of GATA-4 and GATA-5 in human esophageal neoplasia is associated with gene promoter hypermethylation.Imported.
    Source: GeneRIF:140628.

    This publication is mapped to 16 other entries.

  20. 20
    "Evaluation of GATA-4 and GATA-5 methylation profiles in human pancreatic cancers indicate promoter methylation patterns distinct from other human tumor types."
    Fu B., Guo M., Wang S., Campagna D., Luo M., Herman J.G., Iacobuzio-Donahue C.A.
    Cancer Biol. Ther. 6:1546-1552(2007) [PubMed] [Europe PMC] [Abstract]
    Category: Expression.
    Annotation: While hypermethylation of GATA-5 seems to be a universal feature among human tumors infrequent methylation of GATA-4 and its corresponding overexpression appears unique to pancreatic cancer from other tumor types reported thus far.Imported.
    Source: GeneRIF:140628.

    This publication is mapped to 16 other entries.

  21. 21
    Category: Function.
    Annotation: Methylation of GATA4/5 is a common and specific event in colorectal carcinomas and GATA4/5 exhibit tumor suppressive effects in colorectal cancer cells in vitro. GATA4 methylation in fecal DNA may be of interest for colorectal cancer detection.Imported.
    Source: GeneRIF:140628.

    This publication is mapped to 16 other entries.

  22. 22
    "Methylation of GATA-4 and GATA-5 and development of sporadic gastric carcinomas."
    Wen X.Z., Akiyama Y., Pan K.F., Liu Z.J., Lu Z.M., Zhou J., Gu L.K., Dong C.X., Zhu B.D., Ji J.F., You W.C., Deng D.J.
    World J. Gastroenterol. 16:1201-1208(2010) [PubMed] [Europe PMC] [Abstract]
    Category: Sequences.
    Annotation: Epigenetic inactivation of GATA-5 by methylation of CpG islands is an early frequent event during gastric carcinogenesis and is significantly correlated with H. pylori infection.Imported.
    Source: GeneRIF:140628.

    This publication is mapped to 16 other entries.

  23. 23
    "Epigenetic subgroups of esophageal and gastric adenocarcinoma with differential GATA5 DNA methylation associated with clinical and lifestyle factors."
    Wang X., Kang G.H., Campan M., Weisenberger D.J., Long T.I., Cozen W., Bernstein L., Wu A.H., Siegmund K.D., Shibata D., Laird P.W.
    PLoS ONE 6:e25985-e25985(2011) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Pathology & Biotech.
    Annotation: Two new epigenetic subgroups of gastroesophageal adenocarcinomas were identified that differ to some extent in their survival rates risk factors of exposure and GATA5 DNA methylation.Imported.
    Source: GeneRIF:140628.
  24. 24
    "Upstream stimulatory factor 1 activates GATA5 expression through an E-box motif."
    Chen B., Hsu R., Li Z., Kogut P.C., Du Q., Rouser K., Camoretti-Mercado B., Solway J.
    Biochem. J. 446:89-98(2012) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: USF1 transactivates GATA5 expression by binding to the E-box in its promoterImported.
    Source: GeneRIF:140628.

    This publication is mapped to 12 other entries.

  25. 25
    "Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinoma."
    Peters I., Dubrowinskaja N., Kogosov M., Abbas M., Hennenlotter J., von Klot C., Merseburger A.S., Stenzl A., Scherer R., Kuczyk M.A., Serth J.
    BMC Cancer 14:101-101(2014) [PubMed] [Europe PMC] [Abstract]
    Category: Expression.
    Annotation: Reduced GATA5 mRNA levels are associated with a poor clinical outcome indicating a possible role of GATA5 for the development of aggressive clear cell renal cell carcinoma.Imported.
    Source: GeneRIF:140628.
1 to 25 of 40  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again